Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 22, 2014
Pharmacy Choice - News - Generic Drugs - November 22, 2014

Pharmacy News

 Generic Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 70     Next >>     Go To Page:

11/22/14 - Generic drug prices skyrocket in past year [Chicago Tribune]
The 44- year-old piano tuner and guitar instructor from Elgin, who has health insurance, used to pay $20 for a three-month supply of his generic epilepsy drug as a member of Walgreen's Prescription Savings Club. But in the past year, the price of many generics is disconcertingly moving in the wrong direction, drawing the attention of Congress and p
11/21/14 - Anti-Migraine Drugs Market Research Reports And Industry Analysis 2014-19
In the coming years, the market for anti-migraine drugs is anticipated to witness several launches of new generic migraine drugs that will steadily increase the drug-treatment levels and rate of diagnosis paving a sustainable path to an annual global growth of the overall anti-migraine drugs market. View Full Report at...
11/21/14 - drug supply genrcios, antibiotics, antineoplastic, analgesics, anesthetics and bisphosphonates for the pharmacy department of the university... [TendersInfo (India)]
P. A. 2014-0-57: Supply of Generic Drugs, Antibiotics, Antineoplastic, Analgesics, Anesthetics and Bisphosphonates for the Pharmacy Department of the University Hospital October 12. Total quantity or scope: This contract is divided into lots: yes Estimated value excluding VAT: 1 180 591,47 EUR Deposits and Guarantees required: Provisional Warranty
11/21/14 - Generic drug prices skyrocket in past year [Chicago Tribune]
The 44- year-old piano tuner and guitar instructor from Elgin, who has health insurance, used to pay $20 for a three-month supply of his generic epilepsy drug as a member of Walgreen's Prescription Savings Club. But in the past year, the price of many generics is disconcertingly moving in the wrong direction, drawing the attention of Congress and p
11/21/14 - Hospira Announces U.S. Launch of Generic Paricalcitol Injection
By a News Reporter-Staff News Editor at Health& Medicine Week Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, announced the launch of Paricalcitol Injection, a generic version of AbbVie's Zemplar. Hospira obtained U.S. Food and Drug Administration approval of paricalcitol on Oct. 21 and launched the prod
11/21/14 - New Findings from Free University Update Understanding of Chromatography (Generic chiral method development in supercritical fluid chromatography and...
By a News Reporter-Staff News Editor at Science Letter Investigators discuss new findings in Science. According to news reporting from Brussels, Belgium, by NewsRx journalists, research stated, "The development of chiral separation methods in pharmaceutical industry is often a very tedious, labour intensive and expensive process. The news corresp
11/21/14 - North American Business Headlines At 6:21 a.m. EST
Japan orders air bag maker to conduct probe Soaring generic drug prices draw Senate scrutiny Hearing draws apology, admission in air bag mess Global stocks mostly higher, yen rises Judge: Monroe letter belongs to auction buyer Thanksgiving getaway: 46.3 million to hit the road L.A. becomes stage for high-speed luxury cars Gift Guide: Help your self
11/21/14 - North American Business Headlines At 6:25 a.m. EST
CEOs in 10 big mergers to get $430 M: Equilar study Japan orders air bag maker to conduct probe Soaring generic drug prices draw Senate scrutiny Hearing draws apology, admission in air bag mess Global stocks mostly higher, yen rises Judge: Monroe letter belongs to auction buyer Thanksgiving getaway: 46.3 million to hit the road L.A. becomes stage f
11/21/14 - North American Business Headlines At 7:10 a.m. EST
CEOs in 10 big mergers to get $430 M: Equilar study Japan orders air bag maker to conduct probe Soaring generic drug prices draw Senate scrutiny Hearing draws apology, admission in air bag mess Global stocks mostly higher, yen rises Judge: Monroe letter belongs to auction buyer Thanksgiving getaway: 46.3 million to hit the road L.A. becomes stage f
11/21/14 - North American Business Headlines At 7:23 a.m. EST
China rate cut gives markets a big boost CEOs in 10 big mergers to get $430 M: Equilar study Japan orders air bag maker to conduct probe Soaring generic drug prices draw Senate scrutiny Hearing draws apology, admission in air bag mess Judge: Monroe letter belongs to auction buyer Thanksgiving getaway: 46.3 million to hit the road L.A. becomes stage
11/21/14 - Oncology Biosimilars Market to Grow at 29.87% CAGR to 2018
ReportsnReports.com adds Global Oncology Biosimilars Market 2014-2018 industry research report of 71 pages to the life science intelligence collection of its online library. According to this report, global oncology biosimilars market is forecast to grow at a CAGR of 29.87 percent over the period 2013-2018. Complete report is available at...
11/21/14 - Supernus Sues Zydus for Infringement of Trokendi XR(R) Patents
Supernus Pharmaceuticals, Inc. announced that it sued generic drug makers Zydus Pharmaceuticals Inc. and Cadila Healthcare Limited for infringement of three patents covering its antiepileptic drug Trokendi XR . Filing its Complaint within 45 days of receiving Zydus' Paragraph IV certification notice entitles Supernus to an automatic stay...
11/20/14 - Amneal Launches AG for Novo Nordisk's Activella
Amneal Pharmaceuticals LLC today announced the launch of Lopreeza? tablets in 0.5 mg/0. 1 mg and 1 mg/0. 5 mg strengths. Annual U.S. sales of estradiol/norethindrone acetate tablets were $116 million as of August 2014, according to IMS Health. Amneal Pharmaceuticals LLC is a U.S.-based manufacturer of generic pharmaceuticals.
11/20/14 - Cummings: Sanders and Cummings Introduce Legislation to Require Drug Company Rebates for Generic Drugs
Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, introduced legislation in the Senate and House to require drug companies to reimburse Medicaid if they raise the prices of their generic drugs more quickly than inflation. Current law requires drug companies to pay rebates to Medicaid when they increase th
11/20/14 - Drugmakers Mum on Huge Price Hikes
Bernie Sanders, I-Vt., issued the following news release:. Sharp increases in prices for many generic drugs were examined today at a Senate hearing where three pharmaceutical companies refused to testify. Bernie Sanders, chairman of the Senate Subcommittee on Primary Health and Aging.
11/20/14 - High Priced U.S. Generic Drugs Are Often More Expensive Than Brand Name Counterparts in Other Countries, According to a New Price Analysis by PharmacyChecker.com
As the Senate prepares to hold a hearing about the increasing costs of many generic drugs, PharmacyChecker.com released new data showing that Americans are paying more for many generics than consumers pay for their brand name counterparts in other countries. PharmacyChecker.com verifies online pharmacies and compares prescription drug prices.
11/20/14 - Intellipharmaceutics Announces Appointment of New Chief Financial Officer [Kuwait News Agency]
Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that it has appointed Domenic Della Penna as its new Chief Financial Officer effective November 24, 2014.
11/20/14 - Intellipharmaceutics Notes Launch of 5mg Strength of Focalin XR(R) Generic by Teva
Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that, based on information regarding recent generic introductions by Teva Pharmaceuticals on its website, it believes...
11/20/14 - Justice Department, Senate investigating generic drug price hikes [The Philadelphia Inquirer]
"We are the only country in the world where drug companies can charge whatever they like because they can, and to me, it's not right," said Bridesburg resident Casimir Janczewski, who saw the out-of-pocket price of his generic prescription skin cream rise from about $26 in April to about $112 in October, even with insurance from Aetna. Janczewski's
11/20/14 - Pharmacist Testifies: Generic Drug Price Spikes Wreaking Havoc on Patients, Pharmacists and Health Care Payers
Rob Frankil of Sellersville Pharmacy in Sellersville, Pa. appeared on behalf of the National Community Pharmacists Association at a hearing of the Senate Subcommittee on Primary Health and Aging. "Patients who are uninsured or on Medicare drug plans or high-deductible plans are most directly affected. That astounded one of his patients in the Medi
11/20/14 - Senate Health, Education, Labor and Pensions Subcommittee on Primary Health and Aging Hearing
My name is Aaron Kesselheim. I am an internal medicine physician, lawyer, and health policy researcher in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital in Boston and an Associate Professor of Medicine at Harvard Medical School. The FDA reviews them carefully for purity and bioequivalence with the brand-n
11/20/14 - Soaring generic drug prices draw Senate scrutiny
WASHINGTON Some low-cost generic drugs that have helped restrain health care costs for decades are seeing unexpected price spikes of up to 8,000 percent, prompting a backlash from patients, pharmacists and now Washington lawmakers. Members of the Senate meet Thursday to scrutinize the recent, unexpected trend among generic medicines, which are c
11/20/14 - Statement by Ralph G. Neas, President and CEO, GPhA, Regarding Generic Medicine Costs
Generic Pharmaceutical Association issued the following statement by Ralph G. Neas, President and CEO:. Indeed, the world's leading healthcare analytics firm, IMS Institute for Healthcare Informatics, found that generics saved $239 billion in 2013 and more than $1.46 trillion over the recent decade. That is why the Generic Pharmaceutical Associatio
11/20/14 - Statement by Ralph G. Neas, President and CEO, GPhA, Regarding Proposed Legislation on Generic Drugs
Generic Pharmaceutical Association issued the following statement by Ralph G. Neas, President and CEO:. Indeed, generics saved $239 billion in 2013 and more than $1.46 trillion over the recent decade. Congress should focus on several areas where swift action would facilitate a more competitive marketplace:.
11/19/14 - Ackman's Pershing Square Withdraws Call For Allergan Special Shareholder Meeting
The move, which came a day after Allergan agreed to be acquired by Activas Plc, also signals an end to Ackman's seven-month pursuit for Allergan along with Canadian drug maker Valeant Pharmaceuticals, Inc.. Ackman's Pershing, the largest Allergan shareholder, reportedly bought the 28.8 million shares or 9.7 percent stake in Allergan at an average p
Articles(s): 1 - 25 of 70     Next >>     Go To Page:


© 2014 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Newest and Most Current Medications in the Treatment of Diabetes
This lesson is supported by:
RxSchool
HIV & AIDS Testing & Reporting Guidelines
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415